Source Count: 21 | Weighted Score: 46 | Source Confidence: [5/5] | Primary Tier: 2 | Last Updated: March 11, 2026
Keywords: One Health, zoonosis, zoonotic disease, spillover, veterinary medicine, wildlife health, antimicrobial resistance, emerging infectious disease, pandemic, environmental health, SARS, COVID-19, avian flu, Ebola
Category Tags: medicine-healing, one-health, zoonotic-disease, environmental-health
Cross-References: X_4_12 — Tropical Medicine · X_4_14 — Global Health · ZB_3_06 — Ecology Overview

QUICK SUMMARY

One Health is an integrated, multidisciplinary approach that recognizes that the health of humans, animals, and ecosystems is fundamentally interconnected. The concept — formalized in the early 21st century but building on centuries of comparative medicine — addresses the reality that ~75% of emerging infectious diseases in humans are zoonotic (originating in animal reservoirs): SARS (bats → civets → humans), Ebola (bats → primates → humans), H5N1 avian influenza, MERS (bats → camels → humans), and most likely COVID-19 (SARS-CoV-2 — probable bat origin). One Health also encompasses antimicrobial resistance (AMR — driven in part by extensive antibiotic use in livestock agriculture), food safety (contamination, foodborne disease), environmental degradation (deforestation, habitat fragmentation, and climate change as drivers of disease emergence), and comparative medicine (insights from veterinary medicine informing human health, and vice versa). The approach calls for collaboration across traditionally siloed disciplines — human medicine, veterinary medicine, ecology, environmental science, public health, and social science — coordinated through institutions including the WHO-FAO-WOAH (World Organisation for Animal Health) Tripartite, the One Health Commission, and national programs. The COVID-19 pandemic dramatically underscored the urgency of One Health approaches — zoonotic spillover events are expected to increase as deforestation, urbanization, wildlife trade, and climate change expand the interfaces between human, animal, and natural systems.

1. VERIFIED CLAIMS (Tier 1 — Peer-Reviewed / Established)

1.1 Zoonotic Disease Burden

• ~75% of emerging infectious diseases are zoonotic — originating in animal reservoirs and crossing the species barrier to infect humans (Taylor et al. 2001; Jones et al. 2008)
• Major zoonotic pandemics and epidemics: H1N1 influenza (1918 — "Spanish flu," avian origin; 2009 — swine-origin), HIV/AIDS (chimpanzee origin — SIVcpz → HIV-1), SARS (2003 — bat → palm civet → human), MERS (2012 — bat → camel → human), Ebola (multiple outbreaks — bat reservoir → primates/human), SARS-CoV-2 / COVID-19 (2019— probable bat origin, intermediate host debated)
• Drivers of zoonotic emergence: deforestation and land-use change (expanding the human-wildlife interface), wildlife trade (legal and illegal), intensive livestock agriculture (amplification of pathogens among dense animal populations), urbanization, and climate change (shifting vector and reservoir ranges)

1.2 Antimicrobial Resistance (AMR) as a One Health Issue

• Antimicrobial resistance — the ability of microorganisms to survive exposure to antimicrobial drugs — is recognized by WHO as one of the top ten global public health threats
• A significant driver of AMR is the extensive use of antibiotics in livestock agriculture — for growth promotion (now banned in the EU), disease prevention (prophylaxis), and treatment in densely stocked animal populations; resistant bacteria and resistance genes can transfer from animals to humans through food chains, environmental contamination (manure, water), and direct contact
• Estimated mortality: AMR was associated with ~4.95 million deaths globally in 2019 (Murray et al. 2022, The Lancet) — projected to rise significantly without coordinated One Health interventions

1.3 Institutional Framework

• Tripartite: the formal collaboration between WHO (human health), FAO (food and agriculture), and WOAH (World Organisation for Animal Health, formerly OIE) — joined by UNEP in 2022 to form the Quadripartite — coordinating global One Health strategy
• One Health High-Level Expert Panel (OHHLEP): established 2021 by the Quadripartite to provide scientific guidance on pandemic preparedness, zoonotic disease, AMR, food safety, and environmental health

2. CREDIBLE CLAIMS (Tier 2 — Academic / Debated but Supported)

2.1 Historical Roots

• The concept of connections between human and animal health is not new: Rudolf Virchow (19th century) coined the term "zoonosis" and stated "between animal and human medicine there is no dividing line"; William Osler advocated for comparative pathology; Calvin Schwabe promoted "One Medicine" (1984) — the predecessor concept to One Health
• The formal "One Health" concept was articulated clearly in the Manhattan Principles (2004 — Wildlife Conservation Society conference) — calling for an integrated approach to preventing epidemics, noting that barriers between veterinary and human medicine were counterproductive

2.2 Deforestation and Disease Emergence

• Studies demonstrate statistical associations between deforestation, habitat fragmentation, and increased risk of zoonotic disease outbreaks — proposed mechanisms include: increased contact between humans and wildlife at forest edges, altered vector ecology, loss of the "dilution effect" (biodiversity may reduce disease transmission by diluting infected hosts among a wider community of species), and displacement of wildlife into human-dominated landscapes
• The Amazon Basin, Central and West African forests, and Southeast Asian tropical forests are identified as "hotspots" for future zoonotic disease emergence

2.3 Food Safety

• Foodborne zoonotic diseases — including salmonellosis, campylobacteriosis, E. coli O157:H7, listeriosis, and brucellosis — cause an estimated 600 million illnesses and 420,000 deaths per year globally (WHO 2015); the farm-to-fork continuum requires One Health surveillance integrating animal health, food production, and human clinical data

3. SPECULATIVE CLAIMS (Tier 3 — Possible but Unverified)

3.1 "Disease X" and Pandemic Prediction

• The WHO's concept of "Disease X" — a placeholder for a currently unknown pathogen that could cause a future pandemic — reflects the recognition that future zoonotic spillover events are virtually certain; however, predicting which specific pathogen will cause the next pandemic remains beyond current capabilities, despite advances in viral surveillance, metagenomics, and computational modeling

4. DUBIOUS CLAIMS (Tier 4 — No Credible Source / Contradicted by Evidence)

4.1 Zoonotic Disease as Unrelated to Human Activity

• [REFUTED] The claim that zoonotic disease emergence is random or purely "natural" — evidence overwhelmingly demonstrates that human activities (deforestation, wildlife trade, intensive agriculture, urbanization, climate change) are the primary drivers of increased zoonotic spillover risk; pandemic prevention requires addressing these structural drivers

Counter-Arguments & Criticisms

No significant counter-arguments exist in the scholarly literature for the core claims in this document. One Health: Human, Animal, and Environmental Health Interconnected represents established medical science consensus with no active scholarly dispute over the fundamental claims presented here.

IMAGES

No images assigned yet.

BIBLIOGRAPHY

1. Taylor, Louise H., Sophia M | 2001 | "Risk Factors for Human Disease Emergence" | Philosophical Transactions of the Royal Society B | ∅ | 356::983–989 | Latham, and Mark E.J | ∅ | doi:10.1098/rstb.2001.0888 | ∅ | ∅ | Woolhouse
2. Jones, Kate E., et al | 2008 | "Global Trends in Emerging Infectious Diseases" | Nature | ∅ | 451::990–993 | ∅ | ∅ | doi:10.1038/nature06536 | ∅ | ∅ | ∅
3. Murray, Christopher J.L., et al | 2022 | "Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis" | The Lancet | ∅ | ∅ | 399.10325 : 629 655. )00087-3 | ∅ | doi:10.1016/s0140-6736(22 | ∅ | ∅ | ∅
4. Zinsstag, Jakob, et al (eds.) | 2020 | ∅ | One Health: The Theory and Practice of Integrated Health Approaches | ∅ | ∅ | Wallingford: CAB International | 2nd | doi:10.4414/sanp.2021.03194 | ∅ | ∅ | ∅
5. Schwabe, Calvin W. | 1984 | ∅ | Veterinary Medicine and Human Health | ∅ | ∅ | Baltimore: Williams & Wilkins | 3rd | ∅ | ∅ | ∅ | ∅
6. Karesh, William B., et al. . )61678-x | 2012 | "Ecology of Zoonoses: Natural and Unnatural Histories" | The Lancet | ∅ | 380.9857::1936–1945 | ∅ | ∅ | doi:10.1016/s0140-6736(12 | ∅ | ∅ | ∅
7. Daszak, Peter, Andrew A | 2000 | "Emerging Infectious Diseases of Wildlife — Threats to Biodiversity and Human Health" | Science | ∅ | 287.5452::443–449 | Cunningham, and Alex D | ∅ | ∅ | ∅ | ∅ | Hyatt
8. World Health Organization (corp.) | 2019 | ∅ | Taking a Multisectoral, One Health Approach: A Tripartite Guide to Addressing Zoonotic Diseases | ∅ | ∅ | Geneva: WHO, FAO, OIE | ∅ | ∅ | ∅ | ∅ | ∅
9. Cunningham, Andrew A., Peter Daszak; James L.N | 2017 | "One Health, Emerging Infectious Diseases and Wildlife: Two Decades of Progress?" | Philosophical Transactions of the Royal Society B | ∅ | 372.1725::20160167 | Wood | ∅ | ∅ | ∅ | ∅ | ∅
10. Woolhouse, Mark E.J.; Sonya Gowtage-Sequeria | 2005 | "Host Range and Emerging and Reemerging Pathogens" | Emerging Infectious Diseases | ∅ | 11.12::1842–1847 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
11. Atlas, Ronald M.; Stanley Maloy (eds.) | 2014 | ∅ | One Health: People, Animals, and the Environment | ∅ | ∅ | Washington, DC: ASM Press | ∅ | ∅ | ∅ | ∅ | ∅
12. King, Lonnie J., et al | 2008 | "Executive Summary of the AVMA One Health Initiative Task Force Report" | Journal of the American Veterinary Medical Association | ∅ | 233.2::259–261 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
13. Barrett, Megan A.; Steven A | 2014 | "One Health: Interdependence of People, Other Species, and the Planet" | Jekel's Epidemiology, Biostatistics, Preventive Medicine, and Public Health | ∅ | ∅ | Osofsky | 4th | ∅ | ∅ | ∅ | In ; Philadelphia: Saunders
14. Tang, Julian W., et al | 2006 | "Factors Involved in the Aerosol Transmission of Infection and Control of Ventilation in Healthcare Premises" | Journal of Hospital Infection | ∅ | 64.2::100–114 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
15. Gibbs, E | 2014 | "The Evolution of One Health: A Decade of Progress and Challenges for the Future" | Veterinary Record | ∅ | 174.4::85–91 | Paul J | ∅ | ∅ | ∅ | ∅ | ∅
16. Mackenzie, John S.; Martyn Jeggo | 2019 | "The One Health Approach — Why Is It So Important?" | Tropical Medicine and Infectious Disease | ∅ | 4.2::88 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
17. Van Boeckel, Thomas P., et al | 2015 | "Global Trends in Antimicrobial Use in Food Animals" | Proceedings of the National Academy of Sciences | ∅ | 112.18::5649–5654 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
18. Plowright, Raina K., et al | 2017 | "Pathways to Zoonotic Spillover" | Nature Reviews Microbiology | ∅ | 15::502–510 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
19. Wolfe, Nathan D., Claire Panosian Dunavan; Jared Diamond | 2007 | "Origins of Major Human Infectious Diseases" | Nature | ∅ | 447::279–283 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
20. Destoumieux-Garzón, Delphine, et al | 2018 | "The One Health Concept: 10 Years Old and a Long Road Ahead" | Frontiers in Veterinary Science | ∅ | 5::14 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
21. Tripartite (WHO/FAO/OIE) | 2022–2026 | ∅ | One Health Joint Plan of Action () | ∅ | ∅ | Geneva: WHO, 2022 | ∅ | ∅ | ∅ | ∅ | ∅

CROSS-REFERENCE INDEX

Generated from V4 expansion plan. Last Updated: March 11, 2026

<table border="1" cellpadding="12" cellspacing="0" style="border-collapse: collapse; border: 2px solid #888; margin-top: 2em; background: #fafafa;">

<tr><td>

⚠️ AI-Assisted Research Disclaimer

This document was generated and structured with the assistance of AI tools.

While every effort is made to ensure accuracy, AI-assisted content may

contain errors, misattributions, or unintended inaccuracies. **Always

verify claims, dates, and sources independently** before citing or relying

on any information presented here.

• Sources may contain errors. Bibliography entries and cross-references

are checked by automated systems, but mistakes can occur. If something

looks wrong, it may be.

• Speculative and unverified claims are clearly labeled. This project

uses a four-tier evidence system:

• Tier 1 — Verified: Peer-reviewed, established scientific consensus.
• Tier 2 — Credible: Academically supported, debated but grounded.
• Tier 3 — Speculative: Plausible but unverified by mainstream science.
• Tier 4 — Dubious: No credible support or contradicted by evidence.
• This project maps multiple perspectives — not a single truth. Mainstream,

alternative, and skeptical viewpoints are presented side by side for

critical comparison, not endorsement. Inclusion does not imply agreement.

• We are actively improving. Source verification, factuality scoring,

and bibliography enrichment are ongoing. Each revision adds stronger

citations, corrects identified errors, and expands coverage.

📖 For full details on our verification methodology, scoring systems, and

quality metrics, see: Fact-Checking & Verification Systems

Think Openly. Check the sources. Draw your own conclusions.

</td></tr>

</table>